tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Evommune initiated with a Strong Buy at Raymond James
PremiumThe FlyEvommune initiated with a Strong Buy at Raymond James
30d ago
Evommune’s EVO756 Trial Targets High-Need Urticaria Market: What Investors Should Watch
Premium
Company Announcements
Evommune’s EVO756 Trial Targets High-Need Urticaria Market: What Investors Should Watch
1M ago
Evommune participates in a conference call with William Blair
Premium
The Fly
Evommune participates in a conference call with William Blair
1M ago
Evommune, Inc.: Promising Pipeline and Strategic Trials Drive Buy Rating
PremiumRatingsEvommune, Inc.: Promising Pipeline and Strategic Trials Drive Buy Rating
2M ago
Closing Bell Movers: Broadcom down 5%, Lululemon gains 10%
Premium
The Fly
Closing Bell Movers: Broadcom down 5%, Lululemon gains 10%
2M ago
Evommune reports Q3 EPS ($8.07) vs ($10.47) last year
Premium
The Fly
Evommune reports Q3 EPS ($8.07) vs ($10.47) last year
2M ago
Evommune initiated with an Outperform at William Blair
PremiumThe FlyEvommune initiated with an Outperform at William Blair
2M ago
Promising Outlook for Evommune’s EVO756: Buy Rating Backed by Strong Data and Market Potential
Premium
Ratings
Promising Outlook for Evommune’s EVO756: Buy Rating Backed by Strong Data and Market Potential
2M ago
Evommune initiated with an Overweight at Morgan Stanley
Premium
The Fly
Evommune initiated with an Overweight at Morgan Stanley
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100